These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 28585280)

  • 1. Meta-analysis combining parallel and crossover trials using generalised estimating equation method.
    Curtin F
    Res Synth Methods; 2017 Sep; 8(3):312-320. PubMed ID: 28585280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meta-analysis combining parallel and cross-over trials with random effects.
    Curtin F
    Res Synth Methods; 2017 Sep; 8(3):263-274. PubMed ID: 28429470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meta-analysis combining parallel and cross-over clinical trials. I: Continuous outcomes.
    Curtin F; Altman DG; Elbourne D
    Stat Med; 2002 Aug; 21(15):2131-44. PubMed ID: 12210629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meta-analysis combining parallel and cross-over clinical trials. III: The issue of carry-over.
    Curtin F; Elbourne D; Altman DG
    Stat Med; 2002 Aug; 21(15):2161-73. PubMed ID: 12210631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence from crossover trials: empirical evaluation and comparison against parallel arm trials.
    Lathyris DN; Trikalinos TA; Ioannidis JP
    Int J Epidemiol; 2007 Apr; 36(2):422-30. PubMed ID: 17301102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Empirical evidence of bias in infertility research: overestimation of treatment effect in crossover trials using pregnancy as the outcome measure.
    Khan KS; Daya S; Collins JA; Walter SD
    Fertil Steril; 1996 May; 65(5):939-45. PubMed ID: 8612853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meta-analysis combining parallel and cross-over clinical trials. II: Binary outcomes.
    Curtin F; Elbourne D; Altman DG
    Stat Med; 2002 Aug; 21(15):2145-59. PubMed ID: 12210630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, Analysis, and Reporting of Crossover Trials for Inclusion in a Meta-Analysis.
    Li T; Yu T; Hawkins BS; Dickersin K
    PLoS One; 2015; 10(8):e0133023. PubMed ID: 26284684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Practical approaches for design and analysis of clinical trials of infertility treatments: crossover designs and the Mantel-Haenszel method are recommended.
    Takada M; Sozu T; Sato T
    Pharm Stat; 2015; 14(3):198-204. PubMed ID: 25776032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Power and sample size for GEE analysis of incomplete paired outcomes in 2 × 2 crossover trials.
    Tang Y
    Pharm Stat; 2021 Jul; 20(4):820-839. PubMed ID: 33738918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statistical approaches to trial durations in episodic affective illness.
    Post RM; L'Herrou T; Luckenbaugh DA; Frye MA; Leverich GS; Mikalauskas K
    Psychiatry Res; 1998 Mar; 78(1-2):71-87. PubMed ID: 9579704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On hybrid parallel-crossover designs for assessing drug interchangeability of biosimilar products.
    Chow SC; Song F; Cui C
    J Biopharm Stat; 2017; 27(2):265-271. PubMed ID: 28026996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Aggregated N-of-1 Trials with Parallel and Crossover Randomized Controlled Trials Using Simulation Studies.
    Blackston JW; Chapple AG; McGree JM; McDonald S; Nikles J
    Healthcare (Basel); 2019 Nov; 7(4):. PubMed ID: 31698799
    [No Abstract]   [Full Text] [Related]  

  • 14. Limitations of randomized clinical trials. Proposed alternative designs.
    Cleophas TJ; Zwinderman AH
    Clin Chem Lab Med; 2000 Dec; 38(12):1217-23. PubMed ID: 11205684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of reporting bias on meta-analyses of drug trials: reanalysis of meta-analyses.
    Hart B; Lundh A; Bero L
    BMJ; 2012 Jan; 344():d7202. PubMed ID: 22214754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crossover or parallel design in infertility trials? The discussion continues.
    Cohlen BJ; te Velde ER; Looman CW; Eijckemans R; Habbema JD
    Fertil Steril; 1998 Jul; 70(1):40-5. PubMed ID: 9660418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The place of the crossover design in infertility trials: a maximum likelihood approach.
    McDonnell J; Goverde AJ; Vermeiden JP
    Hum Reprod; 2004 Nov; 19(11):2537-44. PubMed ID: 15459169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Model-Based Assessment of Alternative Study Designs in Pediatric Trials. Part I: Frequentist Approaches.
    Smania G; Baiardi P; Ceci A; Magni P; Cella M
    CPT Pharmacometrics Syst Pharmacol; 2016 Jun; 5(6):305-12. PubMed ID: 27300083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incorporating data from various trial designs into a mixed treatment comparison model.
    Schmitz S; Adams R; Walsh C
    Stat Med; 2013 Jul; 32(17):2935-49. PubMed ID: 23440610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A meta-analysis combining parallel and cross-over randomized controlled trials to assess impact of iodine fortified foods on urinary iodine concentration among children.
    Athe R; Mendu VV; Krishnapillai MN
    Asia Pac J Clin Nutr; 2015; 24(3):496-503. PubMed ID: 26420192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.